Increased acute invasive fungal rhinosinusitis in COVID-19 patients

Serap Bulut Çöbden; İbrahim Özcan; Altan Kaya; Yunus Kantekin; Serkan Altıparmak; Mustafa Alkaya; Ali Bayram; Hafize Sav

Article Details

Increased acute invasive fungal rhinosinusitis in COVID-19 patients

Authors:

Serap Bulut Çöbden | İbrahim Özcan | Altan Kaya | Yunus Kantekin | Serkan Altıparmak | Mustafa Alkaya | Ali Bayram | Hafize Sav

Publisher:

MediHealth Academy Yayıncılık

Main Topics:

Sağlık Kurumları Yönetimi

Journal:

Journal of Health Sciences and Medicine Vol.6 Issue 3, pp.656-661

Document Type:

Article

Publication Date:

5/2023

Document Language:

English

Document ID (Org No.):

2001290578

pISSN:

2636-8579

Keywords:

Abstract:

 Aim: Acute invasive fungal rhinosinusitis AIFRS is a rare infection of the nose and paranasal sinuses that can be fatal. Infection may lead to tissue infarction, necrosis, and thrombosis and rapidly spread intracranially. The aim of this study is to highlight the increasing cases of AIFRS after covid-19 and to investigate the parameters affecting mortality. Material and Method: Total 11 patients diagnosed with AIFRS after COVID-19 were included in this study. Patient age, gender, comorbid diseases, initial symptoms, time between COVID-19 diagnosis and AIFRS diagnosis, intensive care hospitalization history, medical treatments, surgical findings, antifungal treatment, fungal species grown in culture, mortality, and the relationships of these parameters with mortality were also evaluated. Results: A total of 11 patients diagnosed with AIFRS after COVID-19 were included in the study. Among these patients, 81.8 were male, 18. 2 were female, and ages ranged from 57 years to 89 years. The mean time between COVID-19 infection and development of IFRS in patients was 26.0918.04 days. The initial symptoms in 45.45 of the patients were unilateral periorbital edema, vision loss, and total ophthalmoplegia. The surgical approach was purely endoscopic in all patients. In our study, the mortality rate was 72.7 in COVID-19 related AIFRS patients. Conclusion: As a result, in our study, we found an increase in AIFRS incidence and mortality due to the systemic effects of COVID 19 and the treatments used for it. AIFRS should be suspected when a patient presents acute sinusitis symptoms after COVID-19 infection.

 Aim: Acute invasive fungal rhinosinusitis AIFRS is a rare infection of the nose and paranasal sinuses that can be fatal. Infection may lead to tissue infarction, necrosis, and thrombosis and rapidly spread intracranially. The aim of this study is to highlight the increasing cases of AIFRS after covid-19 and to investigate the parameters affecting mortality. Material and Method: Total 11 patients diagnosed with AIFRS after COVID-19 were included in this study. Patient age, gender, comorbid diseases, initial symptoms, time between COVID-19 diagnosis and AIFRS diagnosis, intensive care hospitalization history, medical treatments, surgical findings, antifungal treatment, fungal species grown in culture, mortality, and the relationships of these parameters with mortality were also evaluated. Results: A total of 11 patients diagnosed with AIFRS after COVID-19 were included in the study. Among these patients, 81.8 were male, 18. 2 were female, and ages ranged from 57 years to 89 years. The mean time between COVID-19 infection and development of IFRS in patients was 26.0918.04 days. The initial symptoms in 45.45 of the patients were unilateral periorbital edema, vision loss, and total ophthalmoplegia. The surgical approach was purely endoscopic in all patients. In our study, the mortality rate was 72.7 in COVID-19 related AIFRS patients. Conclusion: As a result, in our study, we found an increase in AIFRS incidence and mortality due to the systemic effects of COVID 19 and the treatments used for it. AIFRS should be suspected when a patient presents acute sinusitis symptoms after COVID-19 infection.

 Aim: Acute invasive fungal rhinosinusitis AIFRS is a rare infection of the nose and paranasal sinuses that can be fatal. Infection may lead to tissue infarction, necrosis, and thrombosis and rapidly spread intracranially. The aim of this study is to highlight the increasing cases of AIFRS after covid-19 and to investigate the parameters affecting mortality. Material and Method: Total 11 patients diagnosed with AIFRS after COVID-19 were included in this study. Patient age, gender, comorbid diseases, initial symptoms, time between COVID-19 diagnosis and AIFRS diagnosis, intensive care hospitalization history, medical treatments, surgical findings, antifungal treatment, fungal species grown in culture, mortality, and the relationships of these parameters with mortality were also evaluated. Results: A total of 11 patients diagnosed with AIFRS after COVID-19 were included in the study. Among these patients, 81.8 were male, 18. 2 were female, and ages ranged from 57 years to 89 years. The mean time between COVID-19 infection and development of IFRS in patients was 26.0918.04 days. The initial symptoms in 45.45 of the patients were unilateral periorbital edema, vision loss, and total ophthalmoplegia. The surgical approach was purely endoscopic in all patients. In our study, the mortality rate was 72.7 in COVID-19 related AIFRS patients. Conclusion: As a result, in our study, we found an increase in AIFRS incidence and mortality due to the systemic effects of COVID 19 and the treatments used for it. AIFRS should be suspected when a patient presents acute sinusitis symptoms after COVID-19 infection.

 Aim: Acute invasive fungal rhinosinusitis AIFRS is a rare infection of the nose and paranasal sinuses that can be fatal. Infection may lead to tissue infarction, necrosis, and thrombosis and rapidly spread intracranially. The aim of this study is to highlight the increasing cases of AIFRS after covid-19 and to investigate the parameters affecting mortality. Material and Method: Total 11 patients diagnosed with AIFRS after COVID-19 were included in this study. Patient age, gender, comorbid diseases, initial symptoms, time between COVID-19 diagnosis and AIFRS diagnosis, intensive care hospitalization history, medical treatments, surgical findings, antifungal treatment, fungal species grown in culture, mortality, and the relationships of these parameters with mortality were also evaluated. Results: A total of 11 patients diagnosed with AIFRS after COVID-19 were included in the study. Among these patients, 81.8 were male, 18. 2 were female, and ages ranged from 57 years to 89 years. The mean time between COVID-19 infection and development of IFRS in patients was 26.0918.04 days. The initial symptoms in 45.45 of the patients were unilateral periorbital edema, vision loss, and total ophthalmoplegia. The surgical approach was purely endoscopic in all patients. In our study, the mortality rate was 72.7 in COVID-19 related AIFRS patients. Conclusion: As a result, in our study, we found an increase in AIFRS incidence and mortality due to the systemic effects of COVID 19 and the treatments used for it. AIFRS should be suspected when a patient presents acute sinusitis symptoms after COVID-19 infection.

Article Details

Increased acute invasive fungal rhinosinusitis in COVID-19 patients

Authors:

Serap Bulut Çöbden | İbrahim Özcan | Altan Kaya | Yunus Kantekin | Serkan Altıparmak | Mustafa Alkaya | Ali Bayram | Hafize Sav

Publisher:

MediHealth Academy Yayıncılık

Main Topics:

Sağlık Kurumları Yönetimi

Journal:

Journal of Health Sciences and Medicine Vol.6 Issue 3, pp.656-661

Document Type:

Article

Publication Date:

5/2023

Document Language:

English

Document ID (Org No.):

2001290578

pISSN:

2636-8579

COVID-19

Mucor

AIFRS

ophtalmoplegia

Issues

Article Details

Increased acute invasive fungal rhinosinusitis in COVID-19 patients

Authors: Serap Bulut Çöbden | İbrahim Özcan | Altan Kaya | Yunus Kantekin | Serkan Altıparmak | Mustafa Alkaya | Ali Bayram | Hafize Sav

Publisher: MediHealth Academy Yayıncılık

Main Topics: Sağlık Kurumları Yönetimi

Journal: Journal of Health Sciences and Medicine Vol.6 Issue 3, pp.656-661

Document Type: Article

Publication Date: 5/2023

Document Language: English

Document ID (Org No.): 2001290578

pISSN: 2636-8579

COVID-19

Mucor

AIFRS

ophtalmoplegia

Issues

Authors:

Serap Bulut Çöbden | İbrahim Özcan | Altan Kaya | Yunus Kantekin | Serkan Altıparmak | Mustafa Alkaya | Ali Bayram | Hafize Sav

Publisher:

MediHealth Academy Yayıncılık

Main Topics:

Sağlık Kurumları Yönetimi

Journal:

Journal of Health Sciences and Medicine Vol.6 Issue 3, pp.656-661

Document Type:

Article

Publication Date:

5/2023

Document Language:

English

Document ID (Org No.):

2001290578

pISSN:

2636-8579